This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why Ensign Group Can be a Smart Addition to Your Portfolio
by Zacks Equity Research
ENSG remains well-poised for growth on growing service revenues, an expanding healthcare portfolio and sufficient cash balance.
Ensign Group (ENSG) Down 5.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Health Enhances Prism Platform for Better Virtual Care
by Zacks Equity Research
TDOC upgrades its Prism platform with AI-powered tools, improved referrals and data integration, enhancing care coordination to bolster its member base.
Brookdale Expands Real Estate Portfolio With Strategic Acquisitions
by Zacks Equity Research
BKD expands its real estate footprint with the closure of two acquisitions.
Ensign Group Expands Healthcare Portfolio With Key Acquisitions
by Zacks Equity Research
ENSG acquires skilled nursing and senior living facilities across four states, expanding its U.S. footprint and bringing higher revenues for its Skilled Services segment.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Acadia Healthcare Q4 Earnings Miss on Reduced Length of Stay
by Zacks Equity Research
ACHC expects revenues to be between $3.3 billion and $3.4 billion in 2025.
Teladoc Health Q4 Loss Widens on Soft Integrated Care Unit
by Zacks Equity Research
TDOC expects revenues in the Integrated Care segment to witness 0-3% growth on a year-over-year basis.
Universal Health Q4 Earnings Beat on Strong Adjusted Admissions
by Zacks Equity Research
UHS' fourth-quarter earnings benefit from rising admissions and patient days. Higher expenses partially offset the positives.
Acadia Healthcare to Report Q4 Earnings: Can it Overcome Rising Costs?
by Zacks Equity Research
ACHC's fourth-quarter earnings are likely to have benefited from growing patient days and admissions.
Brookdale Incurs Loss in Q4 Due to Higher Costs, Shares Up 6%
by Zacks Equity Research
BKD's Q4 results reflect escalating general and administrative costs, partly offset by improved occupancy rates. It projects 2025 adjusted EBITDA within $430-$445 million.
Universal Health to Report Q4 Earnings: What Do the Estimates Say?
by Zacks Equity Research
UHS' fourth-quarter earnings are likely to have benefited from growing admissions and patient days.
Select Medical Q4 Earnings Miss Estimates, Stock Down 7.2%
by Zacks Equity Research
SEM expects revenues to be between $5.4 billion and $5.6 billion, the mid-point of which implies 5.8% growth from the 2024 figure of $5.2 billion.
4 Healthcare Stocks to Buy as the Sector Stages a Comeback
by Abhinab Dasgupta
Buy healthcare stocks like WGS, THC, RIGL and ENSG for steady returns as the focus shifts to the incoming Trump administration's healthcare policies.
Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group
by Zacks Equity Research
Deckers Outdoor, Boot Barn, Addus HomeCare and The Ensign Group have been highlighted in this Screen of The Week article.
Community Health Q4 Earnings Miss on Lower Adjusted Admissions
by Zacks Equity Research
CYH expects 2025 capital expenditures to be in the range of $350-$4000 million.
Pick These 4 Stocks With Impressive Interest Coverage Ratios
by Sumit Singh
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Pediatrix Medical Gears Up for Q4 Results: What to Expect?
by Zacks Equity Research
MD's fourth-quarter results are likely to reflect declining revenues and expenses.
Can Community Health Beat Q4 Earnings on Growing Occupancy?
by Zacks Equity Research
CYH's fourth-quarter earnings are likely to have been aided by higher revenue per adjusted admission.
Zacks.com featured highlights include Tyson Foods, NetApp, NextEra Energy, The Ensign and Central Garden & Pet
by Zacks Equity Research
Tyson Foods, NetApp, NextEra Energy, The Ensign and Central Garden & Pet have been highlighted in this Screen of The Week article.
Here's Why Ensign Group (ENSG) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Tyson Foods, NetApp, NextEra Energy, The Ensign Group and Central Garden & Pet.
Is Ensign Group (ENSG) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Ensign Group (ENSG) possesses solid growth attributes, which could help it handily outperform the market.
Is the Options Market Predicting a Spike in The Ensign (ENSG) Stock?
by Zacks Equity Research
Investors need to pay close attention to The Ensign (ENSG) stock based on the movements in the options market lately.